Toxicology – Boric Acid and Borates

Core concept

Boric acid and borates are boron-containing compounds used in household, industrial, and pesticide products.

Most isolated accidental ingestions cause little or no systemic toxicity, but substantial or repeated exposure can cause a characteristic multisystem syndrome:

GI irritation → dehydration/metabolic abnormalities → erythematous desquamating rash + CNS toxicity + acute kidney injury

The most clinically important principle is:

Acute single ingestion is often less dangerous than older toxicology texts suggested, whereas repeated exposure—especially in infants or patients with renal impairment—can produce severe toxicity.

A poison-center series of 784 ingestions found no severe toxicity and found that 88% of patients were asymptomatic.

Forms and Uses

Boric acid

Usually encountered as:

• White powder
• Crystals
• Granules
• Solutions

Borax

Borax = sodium tetraborate, usually encountered as:

• Sodium tetraborate decahydrate
• Sodium tetraborate pentahydrate
• Anhydrous sodium tetraborate

Common uses include:

• Household cleaning products
• Ant and cockroach insecticides
• Wood preservatives
• Glass and ceramic manufacture
• Glazes and enamels
• Fire-resistant materials
• Industrial cleaning compounds

Boron is also naturally present in:

• Food
• Water
• Soil

Routes of Exposure

Potential routes include:

• Ingestion
• Dermal exposure
• Eye exposure
• Inhalation of dust

Systemic toxicity is most important after oral exposure.

Boron is absorbed through the gastrointestinal tract and is eliminated predominantly through the kidneys. More than 90% of an absorbed dose may ultimately be excreted in urine.

Toxic Dose

There is no reliably defined human toxic dose.

Historical estimates suggested minimum lethal oral doses of approximately:

• Adults: 5–20 g
• Children: 3–6 g
• Infants: <5 g

However, these estimates should be interpreted cautiously because human dose-response relationships are extremely variable.

Large clinical series have demonstrated patients remaining asymptomatic after surprisingly large acute ingestions, and serum concentrations correlate poorly with clinical severity.

Therefore:

Do not use dose alone to predict severity.

Consider:

• Amount
• Concentration
• Acute versus repeated exposure
• Age
• Clinical symptoms
• Renal function

High-Risk Patients

Greater concern is warranted in:

• Infants
• Young children
• Patients with renal impairment
• Repeated/chronic exposure
• Large intentional ingestion
• Significant dehydration

Reduced renal clearance can prolong systemic exposure and substantially increase toxicity. A 2026 case demonstrated clinically important toxicity after approximately 6 g in an older patient with chronic kidney disease.

Pathophysiology

The precise cellular mechanism of severe boric acid toxicity remains incompletely understood.

Important toxicokinetic features include:

• Efficient GI absorption
• Relatively little metabolism
• Predominantly renal elimination
• Prolonged exposure when kidney function is impaired

Major target systems include:

• Gastrointestinal tract
• Skin
• Central nervous system
• Kidneys

Clinical Features

Gastrointestinal Toxicity

The most common manifestations of acute ingestion are:

• Nausea
• Vomiting
• Abdominal pain
• Diarrhea

Vomitus or diarrhea has classically been described as blue-green, although this finding is neither sensitive nor required for diagnosis.

Severe cases may cause:

• Hematemesis
• Hematochezia
• Severe fluid loss
• Dehydration

Large poison-center series confirm that vomiting, abdominal pain, and diarrhea are the most common manifestations after acute ingestion.

Dermatologic Toxicity

A classic severe manifestation is a diffuse erythematous eruption sometimes described as:

“Boiled lobster” rash

This may progress to:

• Generalized erythema
• Desquamation
• Exfoliation

Severe historical cases can resemble extensive exfoliative dermatitis.

NPIC describes extreme exposures producing a red skin eruption followed by skin loss.

Neurologic

Severe poisoning may cause:

• Irritability
• Headache
• Confusion
• Abnormal movements
• Tremor
• Altered mental status
• Seizures
• Coma

Neurologic toxicity has been particularly described after large or repeated exposure in infants.

Renal

Possible manifestations include:

• Elevated creatinine
• Oliguria
• Acute kidney injury
• Rarely anuric renal failure

Renal dysfunction is especially important because:

Reduced elimination → greater boric acid accumulation → worsening toxicity

This can create a cycle of progressive exposure in patients with pre-existing or newly developing renal impairment.

Fluids, Electrolytes, and Acid-Base

Severe vomiting and diarrhea may cause:

• Dehydration
• Hypernatremia
• Hyperchloremia
• Electrolyte abnormalities
• Metabolic acidosis

Severe systemic illness may further worsen metabolic acidosis.

HEENT

Exposure may cause:

• Oral or mucous-membrane irritation
• Eye irritation
• Conjunctivitis

Borax dust can also produce:

• Dry nose and throat
• Sore throat
• Epistaxis

Pulmonary

Inhalation of borate dust may cause:

• Cough
• Throat irritation
• Dyspnea
• Upper respiratory tract irritation

NIOSH lists the respiratory tract, eyes, and skin among the principal targets of occupational sodium borate exposure.

Diagnosis

Diagnosis is primarily based on:

Exposure history + characteristic gastrointestinal, dermatologic, neurologic, or renal findings

No single laboratory value reliably determines severity.

Laboratory Investigations

Mild/asymptomatic exposure

Extensive laboratory testing is generally unnecessary.

Significant or symptomatic exposure

Consider:

• Serum electrolytes
• Bicarbonate
• BUN
• Creatinine
• Glucose
• Blood gas
• Urinalysis

In intentional overdose also consider:

• Acetaminophen concentration
• Salicylate concentration
• Relevant coingestants

Serum Boron / Boric Acid Concentrations

Specialized laboratories can measure:

• Serum boron
• Serum boric acid

These concentrations can confirm exposure but:

They correlate poorly with clinical toxicity.

In the 784-patient series, several patients with substantially elevated concentrations remained entirely asymptomatic.

Therefore, treatment should be guided primarily by:

• Clinical condition
• Renal function
• Estimated exposure
• Evolution of symptoms

rather than a single concentration.

Treatment

1. Supportive Care

There is no specific antidote.

Treatment centers on:

• Airway and breathing support
• IV fluids when needed
• Correction of electrolyte abnormalities
• Management of seizures
• Renal support
• Treatment of shock

2. Fluid Resuscitation

Vomiting and diarrhea may cause substantial volume depletion.

Use isotonic crystalloid to:

• Restore intravascular volume
• Maintain renal perfusion
• Correct dehydration

Fluid administration should be individualized, particularly if acute kidney injury develops.

The historical recommendation to force urine output to a specific target should not be applied rigidly.

Gastrointestinal Decontamination

Do Not Induce Vomiting

The historical recommendation for ipecac-induced emesis is obsolete.

Do not administer ipecac and do not induce vomiting.

Activated Charcoal

Activated charcoal is not routinely recommended for isolated boric acid ingestion.

Boric acid binds poorly to activated charcoal; experimentally, impractically large charcoal doses would be required for meaningful adsorption.

Gastric Lavage

Routine gastric lavage is also not recommended in contemporary poisoning management.

For most acute exposures:

Supportive care and clinical observation are preferable to aggressive GI decontamination.

A large clinical series concluded that aggressive treatment is unnecessary in most single acute boric acid ingestions.

Skin Exposure

For dry powder:

• Remove contaminated clothing
• Brush or wipe off excess dry material first when practical
• Wash thoroughly with water and soap

For liquid exposure:

• Irrigate exposed skin thoroughly with water

Extensive exposure through damaged skin deserves greater attention because intact skin is a better barrier than compromised skin.

Eye Exposure

Immediately irrigate with:

• Water
• Normal saline

Persistent:

• Pain
• Redness
• Photophobia
• Visual disturbance

requires further ocular evaluation.

Inhalation

• Remove from exposure
• Move to fresh air
• Provide respiratory support if necessary

Persistent cough or dyspnea warrants medical assessment.

Seizures

Treat seizures according to standard toxicologic seizure management, generally beginning with:

Benzodiazepines

while correcting:

• Hypoxia
• Glucose abnormalities
• Electrolyte abnormalities
• Significant acidosis

Hemodialysis

Boric Acid Is Dialyzable

Boric acid has properties favorable for extracorporeal removal:

• Small molecular size
• Predominantly renal elimination
• Relatively low volume of distribution

Hemodialysis can markedly increase elimination.

One pharmacokinetic study reduced the serum boric acid half-life from approximately 13.5 hours to 3.8 hours during hemodialysis.

When to Consider Hemodialysis

Dialysis is not required for most isolated acute ingestions.

Consider it in severe poisoning, especially with:

• Significant acute kidney injury
• Pre-existing renal impairment
• Severe neurologic toxicity
• Hemodynamic deterioration
• Severe metabolic abnormalities
• Very large exposure with significant symptoms
• Persistent high systemic burden with impaired elimination

Recent reports continue to support extracorporeal therapy in severe poisoning, particularly when renal function is impaired.

Continuous Renal Replacement Therapy

When severe toxicity coexists with hemodynamic instability, continuous hemodiafiltration/continuous renal replacement therapy may be considered when intermittent hemodialysis is poorly tolerated.

Peritoneal Dialysis

Older reports used peritoneal dialysis.

Modern extracorporeal treatment, when required, generally favors hemodialysis or appropriate continuous renal replacement therapy because clearance is more predictable.

Exchange Transfusion

Exchange transfusion is primarily a historical therapy and is not routine contemporary management.

Antidote

There is no specific antidote for boric acid or borate poisoning.

Management consists of:

Stop exposure + supportive care + correct fluid/electrolyte abnormalities + dialysis for selected severe cases

Occupational Exposure

Sodium Tetraborate – Anhydrous

NIOSH REL:

1 mg/m³ TWA

The current NIOSH Pocket Guide lists no specific current OSHA PEL for this material.

Sodium Tetraborate – Pentahydrate

NIOSH REL:

1 mg/m³ TWA

Again, the current NIOSH Pocket Guide lists no specific OSHA PEL.

Sodium Tetraborate – Decahydrate

NIOSH REL:

5 mg/m³ TWA.

The older source’s statement that OSHA has a 10 mg/m³ PEL for these sodium borates should not be treated as a current specific OSHA standard. The historical rule establishing such limits was later remanded.

Monitoring

Patients with significant toxicity should have serial monitoring of:

• Mental status
• Vital signs
• Fluid balance
• Electrolytes
• Bicarbonate
• BUN
• Creatinine
• Urine output

Severe cases may additionally require:

• Continuous cardiorespiratory monitoring
• Serial blood gases
• Serial boron concentrations when available and clinically useful

Admission

Hospital admission is appropriate for:

• Persistent vomiting or diarrhea
• Significant dehydration
• Electrolyte abnormalities
• Metabolic acidosis
• Acute kidney injury
• Altered mental status
• Seizures
• Significant skin manifestations
• Hemodynamic instability
• Substantial repeated exposure

Severe neurologic, renal, or hemodynamic toxicity warrants ICU-level care.

Prognosis

Most single acute ingestions have a favorable prognosis.

The large poison-center series found:

• 88.3% completely asymptomatic
• No severe toxicity among 784 cases
• GI symptoms as the predominant clinical manifestations

Severe poisoning is more likely after:

• Repeated exposure
• Large exposure
• Infant exposure
• Renal impairment

Recovery may be prolonged if:

• Acute kidney injury develops
• Severe neurologic toxicity occurs
• Significant tissue injury develops

Important Pitfalls

1. Assuming a few grams is automatically lethal

Older texts frequently describe surprisingly low lethal doses.

Modern clinical data demonstrate wide variability, and many substantial single acute ingestions produce only mild or no symptoms.

The patient should be managed according to clinical findings and risk factors, not historical dose thresholds alone.

2. Underestimating repeated exposure

Historically severe and fatal cases frequently involved:

Repeated administration, particularly in infants

rather than a single accidental taste.

3. Missing renal impairment

Because boron is predominantly renally eliminated:

Renal dysfunction can substantially prolong toxicity.

4. Using activated charcoal

Boric acid is poorly adsorbed by activated charcoal, so routine charcoal is not useful.

5. Using ipecac

Ipecac-induced vomiting is obsolete and should not be used.

6. Relying on serum boron concentration

Serum values may confirm exposure but correlate poorly with clinical severity.

7. Missing the characteristic skin syndrome

Severe poisoning may produce:

Diffuse erythema → “boiled lobster” appearance → desquamation

High-Yield Toxicology Pearls

Boric acid/borates = GI toxicity + rash + CNS toxicity + renal injury

Think:

Repeated/large exposure + vomiting/diarrhea + red desquamating rash + AKI ± CNS changes

Key points:

• Boric acid is absorbed orally and eliminated mainly through the kidneys
• Most single acute accidental ingestions cause minimal or no systemic toxicity
• Repeated exposure can be much more dangerous
• Infants and patients with renal impairment are higher risk
• Common acute symptoms: vomiting, abdominal pain, diarrhea
• Classic severe skin finding: “boiled lobster” erythema with desquamation
• Severe toxicity may cause seizures, coma, metabolic acidosis, and AKI
• Serum boron concentrations correlate poorly with severity
• No specific antidote
• Do not induce vomiting
• Activated charcoal is not routinely useful
• Routine gastric lavage is not recommended
• Main treatment: supportive care and fluid/electrolyte management
• Hemodialysis can markedly enhance elimination and should be considered in selected severe cases, especially with renal impairment
• NIOSH REL for sodium tetraborate:
• Anhydrous: 1 mg/m³ TWA
• Pentahydrate: 1 mg/m³ TWA
• Decahydrate: 5 mg/m³ TWA